2nd Quarter - Report

WINSTON TAYLOR LLP (FORMERLY KNOWN AS WINSTON & STRAWN LLP) for FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC )

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Represent the client on issues related to assuring a safe, reliable supply of heparin and vancomycin.

LobbyistCovered position, as disclosed
JOHN D MCMICKLE —
THOMAS L MILLS —
ERIC J SILVA —
JOHN A WAITS —

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.